Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
IBO Impact BioMedical
- 1.890
- -0.260-12.09%
Close Dec 13 16:00 ET
- 1.890
- 0.0000.00%
Post 16:07 ET
21.74MMarket Cap18.71P/E (TTM)
2.330High1.890Low16.91KVolume2.260Open2.150Pre Close36.22KTurnover1.13%Turnover RatioLossP/E (Static)11.50MShares3.25052wk High0.69P/B2.84MFloat Cap1.22052wk Low--Dividend TTM1.50MShs Float3.250Historical High--Div YieldTTM20.47%Amplitude1.220Historical Low2.142Avg Price1Lot Size
Impact BioMedical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -91.51%-1.29M | 9.14%-666K | 29.78%-712K | -27.16%-2.85M | -19.28%-433K | 16.33%-671K | -34.74%-733K | -90.24%-1.01M | 0.00%-2.24M | 63.88%-363K |
| Net income from continuing operations | 460.49%4.24M | 21.25%-882K | -17.55%-998K | 39.26%-4.41M | 62.54%-1.26M | 49.79%-1.18M | -40.18%-1.12M | -13.81%-849K | 0.00%-7.26M | 37.11%-3.37M |
| Depreciation and amortization | 0.36%281K | -0.36%279K | 0.00%280K | 0.63%1.12M | 0.72%280K | 0.36%280K | 0.72%280K | 0.72%280K | 0.00%1.11M | 0.00%278K |
| Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%-621K | -378.12%-1.88M |
| Change In working capital | -161.50%-139K | -158.88%-63K | 101.35%6K | 3.56%436K | 8.73%548K | 4,420.00%226K | 565.22%107K | -584.62%-445K | 0.00%421K | 39.23%504K |
| -Change in receivables | 36.17%128K | ---- | ---- | ---128K | ---128K | --94K | ---- | ---- | --0 | ---- |
| -Change in prepaid assets | -559.18%-323K | -129.41%-40K | 97.47%-2K | 273.33%104K | 328.57%96K | -288.46%-49K | 2,042.86%136K | -113.51%-79K | 0.00%-60K | -320.00%-42K |
| -Change in payables and accrued expense | -69.06%56K | -135.38%-23K | 102.19%8K | -4.37%460K | 6.23%580K | 412.07%181K | 209.52%65K | -1,207.14%-366K | 0.00%481K | 66.46%546K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -91.51%-1.29M | 9.14%-666K | 29.78%-712K | -27.16%-2.85M | -19.28%-433K | 16.33%-671K | -34.74%-733K | -90.24%-1.01M | 0.00%-2.24M | 63.88%-363K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 200.00%1K | 109.09%1K | 0 | 95.70%-15K | 100.36%1K | 0.00%-1K | -134.38%-11K | 96.19%-4K | 0.00%-349K | -103.37%-275K |
| Net PPE purchase and sale | --0 | --0 | --0 | 93.48%-18K | --0 | ---1K | ---12K | ---5K | 0.00%-276K | ---276K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%-65K | --0 |
| Net other investing changes | --1K | ---- | ---- | 137.50%3K | 0.00%1K | --0 | -98.82%1K | 101.08%1K | 0.00%-8K | -99.98%1K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 200.00%1K | 109.09%1K | --0 | 95.70%-15K | 100.36%1K | 0.00%-1K | -134.38%-11K | 96.19%-4K | 0.00%-349K | -103.37%-275K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 354.02%3.95M | -10.86%665K | -29.89%713K | 12.49%2.87M | -56.96%232K | 12.55%870K | 22.30%746K | 62.72%1.02M | 0.00%2.55M | 107.46%539K |
| Net issuance payments of debt | -74.25%224K | -10.86%665K | -29.89%713K | 12.49%2.87M | -56.96%232K | 12.55%870K | 22.30%746K | 62.72%1.02M | 0.00%2.55M | 107.46%539K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 354.02%3.95M | -10.86%665K | -29.89%713K | 12.49%2.87M | -56.96%232K | 12.55%870K | 22.30%746K | 62.72%1.02M | 0.00%2.55M | 107.46%539K |
| Net cash flow | ||||||||||
| Beginning cash position | -33.33%2K | 100.00%2K | -50.00%1K | -95.65%2K | 99.01%201K | -97.71%3K | -96.97%1K | -95.65%2K | 0.00%46K | 8.60%101K |
| Current changes in cash | 1,246.46%2.67M | --0 | 200.00%1K | 97.73%-1K | -102.02%-200K | 760.00%198K | -97.96%2K | 92.31%-1K | 0.00%-44K | -52.31%-99K |
| End cash Position | 1,227.36%2.67M | -33.33%2K | 100.00%2K | -50.00%1K | -50.00%1K | 99.01%201K | -97.71%3K | -96.97%1K | 0.00%2K | 0.00%2K |
| Free cash flow | -91.22%-1.29M | 10.60%-666K | 30.13%-712K | -13.94%-2.87M | 32.24%-433K | 16.21%-672K | -36.95%-745K | -91.18%-1.02M | 0.00%-2.52M | 50.12%-639K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
